GlassScriptPhysician profile
Jamil B Alkhaddo
NPI 1700966652
$4,708.34
in general payments reported to CMS, 2019-2025
32 companies · $1,538 in 2025
The $1,538 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $46.49 · 2021: $170 · 2022: $630 · 2023: $1,047 · 2024: $1,066 · 2025: $1,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,579 · Education: $42.50 · Long Term Medical Supply Or Device Loan: $29.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,579.08 |
| Education | $42.50 |
| Long Term Medical Supply Or Device Loan | $29.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $674.57 | 2022-2025 | Cequr Simplicity |
| Novo Nordisk INC | $555.17 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Tandem Diabetes Care, INC. | $364.01 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $324.93 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $267.50 | 2022-2025 | |
| Beta Bionics, INC. | $257.33 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Amgen INC. | $237.14 | 2023-2025 | Tepezza, Enbrel, Tavneos |
| Lilly USA, LLC | $181.54 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Radius Health, INC. | $170.35 | 2019-2025 | |
| Abbott Laboratories | $163.95 | 2022-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Dexcom, INC. | $158.90 | 2023-2025 | Dexcom G6 Transmitter |
| Abiomed | $149.97 | 2025 | |
| Medtronic, INC. | $137.83 | 2023-2025 | Minimed 780g |
| Biohaven Pharmaceutical Holding Company LTD. | $124.52 | 2022 | |
| W. L. Gore & Associates, INC. | $120.01 | 2023 | Seamguard Staple Line Reinforcement |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bigfoot Biomedical INC | $96.36 | 2023 | Unity Diabetes Management System |
| Alexion Pharmaceuticals, INC. | $95.33 | 2023 | Strensiq |
| Sanofi-Aventis U.S. LLC | $89.91 | 2020-2025 | |
| Ascensia Diabetes Care US INC. | $83.60 | 2024-2025 | |
| Corcept Therapeutics | $61.05 | 2025 | Korlym |
| Mannkind Corporation | $59.51 | 2025 | |
| Vifor Pharma, INC. | $50.57 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.59 | 2019-2022 | |
| Astellas Pharma US INC | $47.46 | 2024 | Veozah |
| Senseonics, Incorporated | $43.00 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.73 | 2025 | Caplyta |
| Intra-Sana Laboratories | $31.73 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Insulet Corporation | $18.77 | 2025 | Omnipod |
| Sequel Med Tech, LLC | $18.15 | 2025 | Twiist |
| Halozyme INC | $17.23 | 2023 | |
| Sobi, INC | $13.87 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.76 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamil Alkhaddo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.